SubscribeLogin
Published

OncoVerity Raises Extended Series A

Summary by Citybiz
OncoVerity, an Aurora, CO-based company which specializes in applying advanced bioinformatics to drug development, raised a Series A extension funding. The amount of the deal was not disclosed. The round was led by existing investors argenx and RefinedScience. Led by CEO Max Colao, OncoVerity applies computational tools to clinical and biological data to advance therapies for cancer patients. Through a strategic collaboration with Refined Scienc…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

Aurora, ColoradoAurora, Colorado
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal